Litcius/Paper detail

Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity

Gabriel K. Griffin, Jingyi Wu, Arvin Iracheta‐Vellve, James C. Patti, Jeffrey Hsu, Thomas Davis, Deborah Dele‐Oni, Peter P. Du, Aya Halawi, Jeffrey J. Ishizuka, Sarah Kim, Susan Klaeger, Nelson H. Knudsen, Brian C. Miller, Tung H. Nguyen, Kira E. Olander, Malvina Papanastasiou, Suzanna Rachimi, Emily Robitschek, Emily M. Schneider, Mitchell D. Yeary, Margaret D. Zimmer, Jacob D. Jaffe, Steven A. Carr, John G. Doench, W. Nicholas Haining, Kathleen B. Yates, Robert T. Manguso, B Bernstein

2021Nature363 citationsDOIOpen Access PDF

Topics & Concepts

BiologyEpigeneticsImmune checkpointImmune systemChromatinImmunogenicityCancer researchCell biologyCytotoxic T cellCRISPRGeneticsImmunotherapyGeneIn vitroEpigenetics and DNA MethylationRNA modifications and cancerCRISPR and Genetic Engineering
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity | Litcius